Antibiotic resistance, where disease-causing bacteria evolve resistance to drugs that usually kill them, is a rising problem globally, meaning new antibiotics need to be found. However, it is difficult for researchers to know which parts of bacterial cells to target with new drugs.
A team led by professor Alain Filloux at Imperial College London, and Despoina Mavridou at The University of Texas at Austin has identified a potential drug target that could be an ideal candidate for the development of novel antibiotics. Their findings are published today in Nature Microbiology.
The new drug target, identified in Pseudomonas aeruginosa, is also crucial for the survival of other pathogenic bacteria, including those that cause meningitis, urinary tract infections and staph infections – meaning any antibiotic targeting it could have a range of uses. At the same time, the new antibiotic would not harm the so-called ‘good’ bacteria that live in our gut and support our health.
“The quest for new antibiotic targets is a challenging one,” said co-corresponding author Mavridou, a new assistant professor of molecular biosciences at UT Austin. “Most ubiquitous essential processes are already being inhibited by existing drugs, while specialized antibiotics usually inhibit only one bacterial species. It is exciting to identify a new target, especially one that is found primarily in many pathogens but not in commensal bacteria.”
Different species, and even different strains of the same species of bacteria, can compete for resources by launching weapons that impair or kill their competitors. One of these is a microscopic harpoon, a type of toxin, which several bacteria use to fire arrows at other bacteria.
While several of these toxins are known, the researchers suspected that other toxins, which attack different parts of their rival bacteria, were waiting to be discovered. Using an approach called transposon directed insertion-site sequencing, the team identified both previously known toxins and immunities, as well as a range of new ones.
They then studied one of the new toxin genes, known as Tse8, to find out how it was able to harm bacterial competitors. They found that the toxin impacted the function of a cell component called the transamidosome complex, which is crucial for protein synthesis in certain bacteria. Tse8 causes the transamidosome complex to gum up by overly promoting the recruitment of one of its components, ultimately impairing the growth of the affected bacteria.
“Knowing how the toxin works means we can now seek to find, or design, small molecules that could produce the same effect,” Filloux said.
Mavridou noted that the Tse8 protein as it occurs naturally isn’t likely to be an effective antibiotic in humans. Large proteins like that often elicit an immune response or break down quickly in the body. It can also be hard to get them past the double membranes of gram-negative bacteria.
“The value of the discovery of Tse8 is that it has demonstrated that the transamidosome complex is a useful target for antibiotic discovery,” Mavridou explained.
In addition, the team’s method also could be replicated for finding yet more antibiotic targets that bacteria already exploit when fighting each other.
“At the end of the day, [bacteria] have fought each other for billions of years and surely know the most effective targets to hit in order to kill competitors,” said first author Laura Nolan, from the MRC Centre for Molecular Bacteriology and Infection (CMBI) and the National Heart and Lung Institute at Imperial.
Original Article:Bacterial Warfare Provides New Antibiotic Target
More from:University of Texas at Austin | Imperial College London
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Novel antibiotics
- Novel Antibiotics for the Treatment of Staphylococcus aureus
aureus, have been recently developed. Novel antibiotics, such as linezolid, daptomycin and tigecycline, have been successfully introduced into clinics. Several other antibiotics of different ...
- Researchers discover key functions of therapeutically promising jumbo viruses
Antibiotic medicines became a popular treatment for bacterial infections in the early 20th century and emerged as a transformational tool in human health. Through the middle of the century, novel ...
- The State Of: Antimicrobial Resistance
We take a look at the AMR field, looking at the past, present and future to give you a comprehensive overview of the research landscape.
- A New Class of Antimicrobial Compounds Discovered in Soil Bacteria
Hundreds of thousands of people die every year from antibiotic-resistant infections or from the complications of those infections, and the problem is only | Microbiology ...
- Swedish-led team discovers potential new class of antibiotics, hope for AMR fight
A new antibiotic against gram-negative bacteria hasn’t been developed since the 1970s. Now, a European research team led by Swedish scientists has discovered multi-drug-resistant bug-killing compounds ...
Go deeper with Google Headlines on:
Novel antibiotics
[google_news title=”” keyword=”novel antibiotics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antibiotic resistance
- WHO alarmed by high use of antibiotics in COVID-19 cases
New evidence from the World Health Organization (WHO) has shown that the extensive use of antibiotics during the coronavirus pandemic may have worsened the “silent” ...
- High levels of resistant bacteria found in uncooked meats and raw dog food: ‘Red flag’
High levels of E. coli were found in uncooked meats and raw dog food sold in U.K. grocery stores, according to research presented last week at the ESCMID Global Congress in Barcelona.
- The State Of: Antimicrobial Resistance
We take a look at the AMR field, looking at the past, present and future to give you a comprehensive overview of the research landscape.
- Antibiotic Alternative Produced by Gram-Positive Bacteria
Due to increasing antibiotic resistance in pathogens causing infections, the development of new antibacterial substances is needed. Scientists are testing out a new group of substances produced by ...
- Study reveals high levels of antibiotic resistance in meat sold for consumption
New research presented at the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found substantial levels of resistance to critically important antibiotics in meat sold for ...
Go deeper with Google Headlines on:
Antibiotic resistance
[google_news title=”” keyword=”antibiotic resistance” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]